Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B3878eb60a904fa5e09d02f4ffacc0eae> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B3878eb60a904fa5e09d02f4ffacc0eae NCIT_P378 "NCI" @default.
- B3878eb60a904fa5e09d02f4ffacc0eae type Axiom @default.
- B3878eb60a904fa5e09d02f4ffacc0eae annotatedProperty IAO_0000115 @default.
- B3878eb60a904fa5e09d02f4ffacc0eae annotatedSource NCIT_C138997 @default.
- B3878eb60a904fa5e09d02f4ffacc0eae annotatedTarget "A receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth." @default.